GLP-1 ID Individualized Dosing

Individualized Weight Loss

What to Expect,
starting GLP-1s with Ivim.

GLP-1 Hero Image

Individualized Care, Made Affordable

See your weight
loss Potential

Trustpilot
41.8 lbs
lbs

*Based on Ivim’s published study, Ivim patients following the Ivim Protocol lost an average of 46% more weight over 68 weeks when compared to another published clinical GLP-1 trial that included a daily 500-calorie deficit, 150 minutes of weekly exercise, and in-person counseling every four weeks. Not a head-to-head study. RX required after clinical evaluation. This is a compounded medication and is not FDA-approved. Compounded drugs have not undergone FDA review for safety, efficacy, or quality. See Ivím website for full safety information. Results may vary.

Our Clinical Results*

27%*
weight loss with tirzepatide 
46%
improvement in weight loss reduction 
22%✝
weight loss with semaglutide 

Your Ivím GLP-1 ID Patient Journey

Here’s how it works:

Eligibility & Intake
 Complete a dynamic health questionnaire to assess eligibility.
Consultation
Video or chat visit with an Ivím provider to review history, goals, and create your treatment plan.
Select & Start
Select your individualized plan and pay your program fee. Your provider finalizes your care and sends prescriptions to the pharmacy.
Weekly Check-ins
Complete a quick check-in through the app. Your provider reviews your progress and makes tailored updates to keep your care effective.
Refills & Ongoing Support
Refills are timed to your plan, ensuring consistent care and continuous support every step of the way.

What your individual 
program includes

IVIM
Other
Competitors
Traditional
Medicine
Individualized GLP-1 care model
IN-CLINIC
ONLY
Unlimited provider access
Weekly dose adjustments
1:1 Virtual Holistic Consultations
$850 value
Master classes, group
coaching & community
$500 value
LIMITED
20% off physician
formulated supplements
Easy progress tracking with the
Ivím Health App
LIMITED

What to Expect

Your Ivím GLP-1 ID Patient Journey

Understanding individualized compounded GLP-1 medications

Individualized compounded medications are customized formularies of medications that may be prescribed by physicians to tailor medical therapies to individual patients. Ivim Health provides individualized compounded GLP-1 medications to deliver medical weight loss individualized to each patient.

Individualized compounded GLP-1 medications may be prescribed based on your personal weight loss needs. If your insurance denies name brand GLP-1 coverage or there is a drug shortage for your name brand medication, then your Ivím medical provider will discuss your individualized compounded GLP-1 medication options.

Individualized compounded GLP-1 medications are not covered by insurance, but Ivím provides affordable pricing options to ensure your weight loss goals stay within reach. Often, individualized compounded GLP-1 medications will be up to 85% less than the retail price of the name brand FDA-approved GLP-1 medications like Zepbound®, Mounjaro®, Ozempic® and Wegovy®.

Yes! Individualized compounded GLP-1 medications can be paid for with your HSA or FSA card.

Ivím works with state-licensed, FDA-regulated pharmacies to fulfill our individualized compounded GLP-1 prescriptions for our patients. We assess each pharmacy for strict quality and safety standards.

Yes, individualized compounded GLP-1 medications must be prescribed by a medical provider. Your dedicated Ivím provider will evaluate your eligibility based on your medical questionnaire to ensure the prescribed medication meets your specific medical needs.

The Ivím advantage

Safety & quality

Prescriptions are sent only to FDA-regulated pharmacies adhering to strict regulatory standards.

Patient support

Receive personalized education, training, and guidance throughout your compounded treatment.

Success with Ivím

There are already tens of thousands Ivím member weight loss success stories (and more every day)!

Learn more about GLP-1s

*Based on Ivim’s published study, Ivim patients following the Ivim Protocol lost an average of 46% more weight over 68 weeks when compared to another published clinical GLP-1 trial that included a daily 500-calorie deficit, 150 minutes of weekly exercise, and in-person counseling every four weeks. Not a head-to-head study. RX required after clinical evaluation. This is a compounded medication and is not FDA-approved. Compounded drugs have not undergone FDA review for safety, efficacy, or quality. See Ivím website for full safety information. Results may vary.

*Based on our internal data and individual patient outcomes may vary. This does not constitute a guarantee of specific results.

✝ These results include data from patients using both FDA-approved and compounded formulations.

Individualized virtual integrative medicine (IVIM): A clinical model for enhanced GLP-1 therapeutic outcomes